News and blogs
389 results found.
How a Yorkshire house led to five pioneering research projects
Last year you raised an incredible £1.95m for Blood Cancer UK in the Omaze Millon Pound House Draw. Find out more about the incredible research projects this is helping to support.
Simon Thomas launches new blood cancer projects
Blood Cancer UK reveals that the money from their latest partnership with Omaze UK is their largest single donation to date. The money has now been invested into research via the Omaze x Blood Cancer UK Research Fund.
Louis Walsh's blood cancer
Walsh has a rare form of blood cancer, which affects the plasma cells in the blood.
Scotland drug regulators rule blood cancer isn't cost effective
Yescarta, the blood cancer drug is not to be made available on the NHS in Scotland even though it is in England. Blood Cancer UK says it highlights the inequality in access to blood cancer drugs across the UK.
£4 million research project to establish those with high risk of blood cancer
On World Cancer Day, Blood Cancer UK & The Leukemia & Lymphoma Society announced a £4 million research project into establishing those at high risk of blood cancer.
Blood cancer drug Tepkinly authorised for use on NHS
The drug for diffuse large B-cell lymphoma, Tepkinly, has been authorised for use on the NHS as a third line treatment.
From despair to hope: The Matthew Wilson Multiple Myeloma Fund
Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.
Our response to the Government's plan for UK commercial clinical trials
Refreshing clinical trials activity must benefit people with blood cancer across the UK.
Artist Vicky Yorke shares her range of unique empathy cards
Find out more about the empathy cards created by artist Vicky Yorke, specially for Blood Cancer UK.
Insurance leader Matthew Wilson - our new chair
Matthew Wilson, Insurance leader, is set to be the new Chair of Blood Cancer UK.
Top tips for hosting a charity music event
Top tips for hosting a charity music event from supporter Ed
Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma
Blood Cancer UK are partnering with Amwins Global Risks to raise funds for myeloma
Stay updated with our organisational strategy
The latest news on our organisational strategy.
Research links childhood CT scan exposure to increased blood cancer risk
In new research, scientists have linked increased CT scan exposure to an increased risk of blood cancer in younger people.
How our research gave vaccine answers to people with blood cancer
Read about how our scientists were able to understand the effectiveness of the COVID-19 vaccine for clinically extremely vulnerable people.
The stolen legacy of Henrietta Lacks
Taken without her knowledge, Henrietta's 'immortal' cells have had an everlasting impact on research and medical ethics.
New non-Hodgkin lymphoma drug
A drug for non-Hodgkin lymphoma, epcoritamab, has been authorised for use in the UK for adults.
This MDS World Awareness Day, four people share their story
October 25 every year is World MDS Awareness Day. This year, four people share their story of living with MDS.
Zanabrutinib recommended for adults with CLL in the UK
Zanubrutinib has been recommended for adults with the blood cancer, chronic lymphocytic leukaemia (CLL) in England.
People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.
People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.